Back
Crinetics Pharmaceuticals Quote, Financials, Valuation and Earnings
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
50
CRNX
Crinetics Pharmaceuticals
Last Price:
53.91
Seasonality Move:
3%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Crinetics Pharmaceuticals Price Quote
$53.91
+1.14 (+2.16%)
(Updated: September 19, 2024 at 6:55 PM ET)
Crinetics Pharmaceuticals Key Stats
Sell
50
Crinetics Pharmaceuticals (CRNX)
is a Sell
Day range:
$52.07 - $53.90
52-week range:
$25.35 - $55.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.08%
Volume:
781.1K
Avg. volume:
512.3K
1-year change:
84.32%
Market cap:
$4.2B
Revenue:
$4M
EPS:
$-3.78
How Much Does Crinetics Pharmaceuticals Make?
Data Unavailable
Is Crinetics Pharmaceuticals Growing As A Company?
-
What Is Crinetics Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.6% -
What Is Crinetics Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Crinetics Pharmaceuticals Stock Price Performance
-
Did Crinetics Pharmaceuticals Stock Go Up Last Month?
Crinetics Pharmaceuticals share price went up by 2.23% last month -
Did CRNX's Share Price Rise Over The Last Year?
CRNX share price rose by 84.32% over the past 1 year
What Is Crinetics Pharmaceuticals 52-Week High & Low?
-
What Is Crinetics Pharmaceuticals’s 52-Week High Share Price?
Crinetics Pharmaceuticals has traded as high as $55.78 over the past 52 weeks -
What Is Crinetics Pharmaceuticals’s 52-Week Low Share Price?
Crinetics Pharmaceuticals has traded as low as $25.35 over the past 52 weeks
Crinetics Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Crinetics Pharmaceuticals?
-
How Much Debt Does Crinetics Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Crinetics Pharmaceuticals Have?
Cash and short term investments quarterly total is $863M -
What Is Crinetics Pharmaceuticals’s Book Value Per Share?
Book value per share is 10.47
Is Crinetics Pharmaceuticals Cash Flow Positive?
-
What Is CRNX Cash Flow From Operations?
Cash flow from operations (TTM) is -$178.3M -
What Is Crinetics Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $774.9M -
What Is Crinetics Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$333.9M
Crinetics Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CRNX return on invested capital is -42.43% -
What Is Crinetics Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -37.11% -
What Is CRNX Return On Equity?
ROE is a measure of profitability and is -42.43%
Crinetics Pharmaceuticals Earnings Date & Stock Price
-
What Is Crinetics Pharmaceuticals's Stock Price Today?
A single share of CRNX can be purchased today for 52.77 -
What Is Crinetics Pharmaceuticals’s Stock Symbol?
Crinetics Pharmaceuticals trades on the nasdaq under the ticker symbol: CRNX -
When Is Crinetics Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Crinetics Pharmaceuticals is scheduled on November 7, 2024 -
When Is CRNX's next ex-dividend date?
Crinetics Pharmaceuticals's next ex-dividend date is September 20, 2024 -
How To Buy Crinetics Pharmaceuticals Stock?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Crinetics Pharmaceuticals Competitors
-
Who Are Crinetics Pharmaceuticals's Competitors?
Below is a list of companies who compete with Crinetics Pharmaceuticals or are related in some way:
Crinetics Pharmaceuticals Dividend Yield
-
What Is CRNX Dividend Yield?
Crinetics Pharmaceuticals’s dividend yield currently is 0% -
What Is Crinetics Pharmaceuticals’s Payout Ratio?
Crinetics Pharmaceuticals’s payout ratio is 0% -
When Did Crinetics Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Crinetics Pharmaceuticals’s Dividend Per Share?
Crinetics Pharmaceuticals pays a dividend of $0.00 per share
Crinetics Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -8.79% |
| Revenue: | -59.62% | -14.61% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 69.21 |
| Upside from Last Price: | 31.16% |